FDA approves single-dose propofol amid drug shortage
Editor's Note The Food and Drug Administration (FDA) approved Amneal Pharmaceuticals' Abbreviated New Drug Application for single-dose vials of propofol injectable emulsion, Anesthesiology News August 23 reports. The newly approved formulations include 200 mg/20 mL, 500 mg/50 mL, and 1,000 mg/100 mL vials. Propofol is widely used for anesthesia and…
Unveiling ECRI’s 2024 top 10 health technology hazards list
What is the purpose of the top 10 health technology hazards list, released every year by ECRI? “Our number one goal at ECRI is to reduce preventable harm,” stresses Jason Launders, MSC, former director of operations, device evaluation, at ECRI. “We know that every healthcare provider has a lot they…
FDA: Class I recall of Baxter’s Abacus software app
Editor's Note The Food and Drug Administration (FDA) on July 25 identified the recall by Baxter Healthcare Corporation of its Abacus Order Entry and Calculation Software application as Class I, the most serious. The Abacus software app can translate a physician’s order into a compounded solution. The recall was initiated…
Free Daily News
- AAMI, CTA partners to develop healthcare AI standards
- ECRI issues guidance to address medical supply shortages caused by Hurricane Helene, dockworkers’ strike
- FDA designates Class 1 recall for IPV therapy system
- Study: Early detection of atherosclerosis linked to lower mortality risk
- Repeal of CON laws for ASCs expands healthcare access, number of facilities in rural areas
- Spatial computing trial shows promise for enhancing OR efficiency, reducing strain on surgeons
- Vice presidential debate highlights healthcare, abortion policy differences
- FDA designates Class 1 recalls for infusion pump software, ventilator software
- Health systems face declining margins, cut leadership amid rising costs
- Hurricane disrupts IV fluid manufacturing as hospitals cope with chaos